OTTAWA, June 14, 2018 (GLOBE NEWSWIRE) — Orion Biotechnology Canada Ltd., a developer of novel medicines, today announced the acquisition of K2Biomedical, a specialty pharmaceutical
Ottawa, Canada May 1, 2018 – Orion Biotechnology Canada Ltd., a developer of novel medical treatments, today announced that Jason Burke has been appointed Chief
Ottawa, Canada (PRWEB) April 09, 2018 Orion Biotechnology Canada Ltd., a developer of novel medical treatments, today announced that Jarret Engstrom has joined as the
OTTAWA, March 28, 2018 (GLOBE NEWSWIRE) — Orion Biotechnology Canada Ltd, a developer of novel medical treatments for chronic illness and life-threatening diseases, today announced
OTTAWA, Ontario (PRWEB)March 26, 2018 Orion Biotechnology Canada Ltd., a developer of novel medical treatments, today announced that Mark Groper has joined as the company’s
Ottawa, Canada March 20, 2018 – Orion Biotechnology Canada Ltd today announced it has completed a US$5 million private placement financing late last year. “We
343 Preston Street
11th floor,
Ottawa, On K1S 1N4
CANADA
+1 343.291.1032
Campus Biotech
Innovation Park
Avenue de Sécheron 15
1202 Genève
SWITZERLAND
Orion Biotechnology
Life Science Park
UI Bobrzyńskiego 14
30-348 Krakôw
POLAND
Leave us a message and we will try to respond by the next business day
343 Preston Street
11th floor,
Ottawa, ON K1S 1N4
CANADA
info@orionbiotechnology.com
+1 343.291.1032
Leave us a message and we will try to respond by the next business day
343 Preston Street
11th floor,
Ottawa, ON K1S 1N4
CANADA
info@orionbiotechnology.com
+1 343.291.1032
